India, Nov. 20 -- CytoSorbents Corporation (CTSO,HQE1.F) announced a $6.25 million common stock financing and a concurrent restructuring of its credit facility with Avenue Capital Group. The transacti... Read More
India, Nov. 20 -- MJBizCon, the influential B2B cannabis Conference and Expo, has announced Grammy-nominated artist and Khalifa Kush Co-Founder, Wiz Khalifa, as keynote speaker and concert headliner o... Read More
India, Nov. 20 -- Kingwisoft Technology Group Co Ltd. (8295.HK) revealed Loss for its first half of -RMB55.94 million The company's earnings totaled -RMB55.94 million, or -RMB0.0117 per share. This c... Read More
India, Nov. 20 -- Yeebo (International Holdings) Ltd (0259.HK) reported a profit for its first half that Increased, from the same period last year The company's bottom line came in at HK$2.284 billio... Read More
India, Nov. 20 -- Friday, Annovis Bio, Inc. (ANVS) announced that the U.S. Food and Drug Administration (FDA) has agreed to its Integrated Summary of Safety (ISS) plan for buntanetap, an investigation... Read More
India, Nov. 20 -- A report released by the University of Michigan on Friday showed consumer sentiment in the U.S. improved by more than previously estimated in the month of November. The University o... Read More
India, Nov. 20 -- MEDIROM Healthcare Technologies Inc. (MRM) Wednesday said that it appealed a Nasdaq delisting determination and filed its overdue 2025 annual report on November 18. The company rece... Read More
India, Nov. 20 -- Friday, Johnson & Johnson (JNJ) announced positive results from its Phase 4 STAR study of TREMFYA (guselkumab) in adults with active psoriatic arthritis (PsA) affecting the spine. Th... Read More
India, Nov. 20 -- Shares of Capricor Therapeutics (CAPR) plunged over 70% to $1.63 in after-hours trading on Friday, following disappointing regulatory news related to its lead investigational asset, ... Read More
India, Nov. 20 -- This week's biotech roundup features significant regulatory milestones, corporate restructuring and strategic dealmaking, alongside clinical developments across oncology, neurology, ... Read More